Search

Author/Creator Chartier, M.

1. AB0371 Is Switching from IV To SC Abatacept Therapy Sustainable in The Real World? 1-Year Analysis of The Prospective, International Action Study. (15th July 2016)

Authors:
Alten, R.; Nüßlein, H.; Galeazzi, M.; Lorenz, H.M.; Mariette, X.; Cantagrel, A.; Chartier, M.; Elbez, Y.; Rauch, C.; Le Bars, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
1030
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AB0453 Do Changes in Clinical Practice Over Time in Europe and Canada Have an Impact on Baseline Characteristics of Patients Initiating Intravenous Abatacept in the Action Study?. (9th June 2015)

Authors:
Nüβlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.-M.; Cantagrel, A.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
1047
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. AB0462 Up to 5-year retention of abatacept in belgian patients with moderate-to-severe ra: prospective data from the real-world action study. (12th June 2018)

Authors:
Westhovens, R.; Connolly, S.E.; Margaux, J.; Vanden Berghe, M.; Maertens, M.; Van Den Berghe, M.; Elbez, Y.; Chartier, M.; Baeke, F.; Robert, S.; Malaise, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
1393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. AB0477 Retention Rates and Clinical Outcomes in Cohorts of Patients (Biologic Naïve or Failed Prior Biologics) Treated with Intravenous Abatacept in a Real-World Setting: 6-Month Results from the Action Study. (9th June 2015)

Authors:
Alten, R.; Nüßlein, H.; Galeazzi, M.; Lorenz, H.-M.; Mariette, X.; Cantagrel, A.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74(2015)Supplement 2
Page Start:
1056
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. AB0531 Real-world efficacy and safety of abatacept treatment for RA: 12-month interim analysis of the action study. (23rd January 2014)

Authors:
Nüßlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.M.; Boumpas, D.; Nurmohamed, M.T.; Bensen, W.G.; Burmester, G.R.; Peter, H.H.; Rainer, F.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. AB0532 Effect of prior therapy on the efficacy and safety of abatacept: 6-month analysis of the action study. (23rd January 2014)

Authors:
Nüßlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.M.; Boumpas, D.; Nurmohamed, M.T.; Bensen, W.G.; Burmester, G.R.; Peter, H.H.; Rainer, F.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. ATHENA detector proposal — a totally hermetic electron nucleus apparatus proposed for IP6 at the Electron-Ion Collider. (1st October 2022)

Authors:
Adam, J.; Adamczyk, L.; Agrawal, N.; Aidala, C.; Akers, W.; Alekseev, M.; Allen, M.M.; Ameli, F.; Angerami, A.; Antonioli, P.; Apadula, N.J.; Aprahamian, A.; Armstrong, W.; Arratia, M.; Arrington, J.R.; Asaturyan, A.; Aschenauer, E.C.; Augsten, K.; Aune, S.; Bailey, K.
Journal:
Journal of instrumentation
Issue:
Volume 17:Number 10(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Calibration of the photon spectrometer PHOS of the ALICE experiment. (28th May 2019)

Authors:
Acharya, S.; Acosta, F.T.-.; Adamová, D.; Adhya, S.P.; Adler, A.; Adolfsson, J.; Aggarwal, M.M.; Rinella, G. Aglieri; Agnello, M.; Ahammed, Z.; Ahmad, S.; Ahn, S.U.; Aiola, S.; Akindinov, A.; Al-Turany, M.; Alam, S.N.; Albuquerque, D.S.D.; Aleksandrov, D.; Alessandro, B.; Alfanda, H.M.
Journal:
Journal of instrumentation
Issue:
Volume 14:Number 5(2019)
Page Start:
P05025
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. FRI0235 Adherence to the recommended dosing regimen of abatacept: results from the international, real-world action study. (23rd January 2014)

Authors:
Nüßlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H. M.; Boumpas, D.; Nurmohamed, M. T.; Bensen, W. G.; Burmester, G. R.; Peter, H.-H.; Rainer, F.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A453
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. FRI0318 Two-Year Retention and Effectiveness of IV Abatacept in Real-Life Setting: Results from the Action Study. (10th June 2014)

Authors:
Nüβlein, H.; Alten, R.; Galeazzi, M.; Lorenz, H.-M.; Nurmohamed, M.; Bensen, W.; Burmester, G.-R.; Peter, H.-H.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
500
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗